期刊文献+

坎地沙坦联合卡维地洛治疗原发性高血压左室肥厚 被引量:8

Effects of candesartan combined with carvedilol on left ventricular hypertrophy of essential hypertension
下载PDF
导出
摘要 目的:观察坎地沙坦联合卡维地洛治疗原发性高血压左室肥厚的疗效。方法:82例高血压患者被随机分为两组:观察组41例,予以坎地沙坦+卡维地洛;常规治疗组41例,予以氨氯地平+卡维地洛,共治疗12个月,观察用药后血压、左室结构的变化。结果:与治疗前比较,用药后两组收缩压[常规治疗组(166±14.0)mmHg∶(123±14.8)mmHg,观察组(168±14.5)mmHg∶(127±13.7)mmHg]和舒张压[常规治疗组(103±12.3)mmHg∶(76±13.6)mmHg,观察组(104±13.6)mmHg∶(79±13.2)mmHg]均显著降低(P均<0.05);两组治疗前后血压无显著差异(P均>0.05)。与治疗前比较,观察组室间隔厚度[(1.29±0.3)mm∶(1.12±0.2)mm]及左室后壁厚度[(1.21±0.2)mm∶(0.88±0.09)mm]均明显变薄(P均<0.05);左室重量指数[(138±27.9)g/m2∶(106±19.0)g/m2]明显减少(P<0.05),常规治疗组各项指标无明显变化(P>0.05),观察组较常规治疗组左室后壁厚度、左室重量指数显著改善(P均<0.05)。结论:坎地沙坦联合卡维地洛治疗原发性高血压左室肥厚患者,可安全有效降压,并同时逆转左室肥厚,改善左室舒张功能。 Objective:To observe the therapeutic effects of candesartan combined with carvedilol on left ventricular hypertrophy of essential hypertension(EH).Methods:A total of 82 EH patients were randomly divided into two groups:observing group(n=41),treated with candesartan and carvedilol;routine treatment group(n=41),treated with amlodipine and carvedilol.Changes of blood pressure and structure of left ventricle were observed after drug treatment.Results:(1)After drug treatment,systolic blood pressure [SBP,(123±14.8) mmHg vs.(166±14.0) mmHg] and diastolic blood pressure [DBP,(76±13.6) mmHg vs.(103±12.3) mmHg] significantly decreased in routine treatment group compared with before treatment(P0.05 all).In observing group,SBP [(127±13.7) mmHg vs.(168±14.5) mmHg] and DBP [(79±13.2) mmHg vs.(104±13.6) mmHg] also significantly decreased compared with before treatment(P0.05 all).There were no significant difference between two group for SBP and DBP change(P0.05 all).In observing group,interventricular septal thickness [TVST(1.12±0.2)mm vs.(1.29±0.3)mm],left ventricular posterior wall thickness [LVPWT(0.88±0.09)mm vs.(1.21±0.2)mm] and left ventricular mass index [LVMI(106±19.0)g/m2 vs.(138±27.9) g/m2] significantly decreased(P0.05 all) compated with befare treatment,and LVPWT、LVMI were less than those of routine treatment group(P0.05 all),but those indicators had no significant change after treatment in routine treatment group(P0.05).Conclusion:For patients with essential hypertension and left ventricular hypertrophy,combined treatment with candesartan and carvedilol can lower their blood pressure safely and effectively,and reverse left ventricular hypertrophy.
出处 《心血管康复医学杂志》 CAS 2011年第1期67-70,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 高血压 肥大 左心室 坎地沙坦 卡维地洛 Hypertension Hypertrophy left ventricular Candesartan Carvedilol
  • 相关文献

参考文献7

二级参考文献18

  • 1吴宪红,田文华,曲彦慧.高龄心衰患者药物联合治疗的疗效及安全性评价[J].心血管康复医学杂志,2004,13(4):364-366. 被引量:3
  • 2祝之明,祝善俊.血管紧张素转换酶抑制剂对血管紧张素Ⅱ介导的钙信号传导的作用及其机理研究[J].中华心血管病杂志,1996,24(5):380-383. 被引量:9
  • 3刘培良,陈瑶,李轩,石春来,裴丽峰,靖涛.坎地沙坦和苯那普利治疗高血压病的对照研究[J].心脏杂志,2007,19(1):67-69. 被引量:11
  • 4Kannel WB. Epidemiology and preventiori of cardiac failure: Framingham study insights [J]. Eur Heart J, 1987, 8 (Suppl F) : 23--26.
  • 5Gheorghiade M, Bonow RO. Chronic heart failure in the United States; a manifestation of coronary heart disease [J]. Circlulation, 1998, 97: 282-289.
  • 6Pitt B, Poole-Wilson PA, Segal R, et al. Effect of Losartan compared with captopril on mortality in patients with symptom atic heart failure: Randomized trial-the lorsartan heart failiure survival study ELITE Ⅱ [J]. Lancet, 2000, 355: 1582- 1587.
  • 7AHA Ambulatory blood pressure monitoring to assess the corn parative efficacy and duration of action of a novel new angiotensin Ⅱ receptor blocker-Candesartan [J]. Joel M Neutel Blood Pressure, 2001, 10: 27--32.
  • 8Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese [J]. BrJClinPharmacol, 1995, 40 (2): 141--144.
  • 9Struthers AD. Angiotension Ⅱ receptor antagonisis for heartfailure [J]. Heart, 1998, 80: 5--6.
  • 10Bar C, Nass A, Freeman M, et al. Q-T dispersion and sudden unexpected death in chronic heart failure [J]. Lancet, 1994, 343: 327.

共引文献68

同被引文献55

  • 1卢益中,季乃军,梅益斌,朱春海,陈伟杰.坎地沙坦治疗原发性高血压疗效及安全性分析[J].中国现代应用药学,2008,25(z1):673-675. 被引量:6
  • 2梁毓源.氯沙坦治疗原发性高血压的临床疗效及其对血清脂联素水平的影响[J].医学临床研究,2012,29(6). 被引量:1
  • 3倪玲玲.缬纱坦治疗原发性高血压病的效果观察[J].现代中西医结合杂志,2007,16(12):1626-1626. 被引量:6
  • 4李建新.坎地沙坦治疗高血压逆转左室肥厚改善心功能的临床效果分析.医药前沿,2012,11:202-203.
  • 5Powers BJ,Coeytaux RR,Dolor RJ,et al.Updated report on comparative effectiveness of ACE inhibitors,ARBs,and direct renin inhibitors for patients with essential hypertension:much more data,little new information[J].J Gen Intern Med,2012,27(6):716-729.
  • 6Grosso AM,Bodalia PN,Macallister RJ,et al.Comparative clinical-and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure:a systematic review,meta-and cost-utility analysis[J].Int J Clin Pract,2011,65(3):253-263.
  • 7Minatoguchi S,Aoyama T,Kawai N,et al.Comparative effect of candesartan and amlodipine,and effect of switching from valsartan,losartan,telmisartan and olmesartan to candesartan,on early morning hypertension and heart rate[J].Blood Press,2013,22(Suppl 1):29-37.
  • 8陈金平,刘玉静,于华,等.坎地沙坦联合复方丹参滴丸对老年原发性高血压患者肾功能的影响[J].中国综合临床,2012,28(13):11-12.
  • 9Miao Y,Ottenbros SA,Laverman GD,et al.Effect of a reduction in uric acid on renal outcomes during losartan treatment:a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial[J].Hypertension,2011,58(1):2-7.
  • 10Colombo GL, Caruggi M, Ottolini C, et al. Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy [ J ]. Vasc Health Risk Manag,2008,4( 1 ) :223-234.

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部